Seeking Alpha
01 Sept 2026, 22:52 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
The analyst has set a price target of $49.58 for PACS, representing a 17% upside from the August 31 closing price. — A formal 'Buy' rating and specific price target provide a concrete catalyst for institutional investors to increase positions.
+0.60PACS reported Q2 operating income growth of 35.8% and revenue growth of 9.1%. — Strong operational leverage and growth in the bottom line indicate healthy fundamental performance.
+0.50The addition of Eduro adds 3,633 beds to the portfolio, with a projected $260 million in incremental revenue by 2027 (after a 27% haircut). — Significant capacity expansion provides a clear path for long-term top-line growth.
+0.40Continue reading
6 related stories
Search tags
Same-store occupancy for PACS reached 90.6% in Q2. — High occupancy rates demonstrate strong demand and pricing power within the existing portfolio.
Which stocks this story touches
The analyst rates the stock as a Buy with a price target 17% above the closing price, citing strong revenue and operating income growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
